Product NewsKey European Data Shows Abbott's i-STAT Can Help Improve Clinical Decision-Making and Efficiency in Emergency Situations
Product NewsAlere to Showcase the New Alere™ i Molecular Platform and Bedside Blood Gas Testing with the epoc® System
Product NewsAbbott's First-of-its-Kind Blood Test to Aid in Detecting Early Pregnancy Could Help Doctors Make Faster Treatment Decisions for Women
Product NewsAbbott Receives U.S. FDA Clearance for Freestyle Precision Neo Blood Glucose Monitoring System™
Product NewsFirst-of-its-Kind Diabetes Technology Revolutionizes How Glucose Data is Collected and Analyzed for People in India
Industry NewsInnovative Partnership Expanded to Bring to Market Dual Detection Test for Neglected Tropical Diseases
Product NewsU.S. Food and Drug Administration Grants CLIA Waiver for Alere Determine™ HIV-1/2 Ag/Ab Combo Test
Product NewsAbbott’s Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe
Industry NewsMalaria No More Honors Alere’s Contributions to Diagnosing and Eliminating Malaria in Sub-Saharan Africa
Product NewsAbbott's RealTime High Risk HPV Test is Now Available in Europe for Primary Screening for Cervical Cancer
Product NewsAbbott Receives CE Mark for FreeStyle® Libre, a Revolutionary Glucose Monitoring System for People with Diabetes
Product NewsAbbott Introduces mView Automated Performance Monitoring Service for its m2000 Molecular Diagnostics System
Product NewsAbbott Joins Forces with U.S. Department of Defense to Develop Portable Blood Tests for Evaluating Concussions
Product NewsAbbott Features Diagnostic Solutions in Global Healthcare Environment at IFCC WorldLab Congress 2014
Product NewsBiocartis and Abbott Announce Exclusive Partnership to Develop Multiplex Companion Diagnostics Tests
Product NewsAbbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes
Product NewsFirst Rapid Molecular Diagnostic Test to Detect Influenza A and B Virus in Under 15 Minutes Now Available in Europe
